Takeda Biopharmaceuticals India Private Limited, a global biopharmaceutical leader focused on research and development, has received the Great Place To Work® certification in India for the period of March 2023 to March 2024. The company, previously Baxalta Bioscience India Pvt. Ltd., is committed to fostering a positive work environment, with a focus on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI).
The Great Place To Work® Institute, the worldwide authority on workplace culture, has identified the key characteristics of outstanding workplaces through its research spanning over three decades. The Institute collaborates with more than 1400 organizations across 22 industries in India, helping them build High-Trust, High-Performance Cultures that deliver long-term results.
Takeda’s employees work tirelessly to improve the quality of life for patients and collaborate with healthcare partners across approximately 80 countries and regions. The Great Place to Work® certification in India is an acknowledgment of Takeda’s commitment to cultivating a supportive work environment that values employee well-being, professional development, and alignment with the company’s mission and values.
